Recruiting NA Post-menopause

New treatment option for Post-menopause

Official title Mental Stress Reactivity in Women With CMD

ClinicalTrials.gov ID: NCT05401630

What this study is testing

What it's testing
Coronary Microvascular Dysfunction (CMD) occurs when there are problems in the small blood vessels/arteries of the heart, resulting in persistent chest pain that affects women. There are an estimated 3 million women in the US with CMD and about 100,000 new cases annually.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 45 and older, women only

You may be able to join if

  • CMD Group
  • Symptomatic postmenopausal women with chest pain
  • age≥45 years old
  • willing to undergo cardiac MIBG scan
  • willing to undergo mental stress testing

You likely can't join if

  • Significant epicardial stenosis (defined by coronary stenosis ≥ 70% in any epicardial coronary artery or hemodynamically significant stenosis...
  • Left ventricular systolic dysfunction (ejection fraction ≤ 50%)
  • Heart failure with a preserved ejection fraction
  • Significant anemia or blood dyscrasia
  • Severe uncontrolled hypertension \>180/100
  • Unable to lie flat for mental stress testing
See the full eligibility criteria
Who can join
  • CMD Group
  • Symptomatic postmenopausal women with chest pain
  • age≥45 years old
  • willing to undergo cardiac MIBG scan
  • willing to undergo mental stress testing
  • competent to give informed consent
What rules you out
  • Significant epicardial stenosis (defined by coronary stenosis ≥ 70% in any epicardial coronary artery or hemodynamically significant stenosis determined by fractional flow reserve)
  • Left ventricular systolic dysfunction (ejection fraction ≤ 50%)
  • Heart failure with a preserved ejection fraction
  • Significant anemia or blood dyscrasia
  • Severe uncontrolled hypertension \>180/100
  • Unable to lie flat for mental stress testing
  • Pre-menopausal
  • Pregnant
  • Pericarditis/myocarditis
  • History of percutaneous coronary intervention
  • Coronary artery bypass grafting
  • Acute myocardial infarction/acute coronary syndrome/unstable angina within 1 month
  • Significant valvular disease, including aortic or mitral stenosis
  • Sinus node dysfunction/pacemaker, 2nd or 3rd-degree atrioventricular block
  • Severe lung, renal, liver, or psychiatric illness
  • Current neoplasm
  • History of substance abuse
  • Acute illness such as infection in the previous 4 weeks
  • Life-expectancy less than 2 years
  • Unable to safely withdraw medications for mental stress testing
  • Significant psychiatric illness that precludes safe participation in the study
  • Conditions that preclude accurate or safe testing and patient refusal
  • Unable to consent Obstructive CAD (oCAD) Group Inclusion Criteria:
  • Symptomatic postmenopausal women with chest pain who have obstructive CAD in at least one epicardial coronary artery
  • willing to undergo cardiac MIBG scan
  • willing to undergo mental stress testing
  • competent to give informed consent Exclusion Criteria:
  • Significant epicardial stenosis (defined by coronary stenosis ≥ 70% in any epicardial coronary artery or hemodynamically significant stenosis determined by fractional flow reserve)
  • Left ventricular systolic dysfunction (ejection fraction ≤ 50%)
  • Heart failure with a preserved ejection fraction
  • Significant anemia or blood dyscrasia
  • Severe uncontrolled hypertension \>180/100
  • Unable to lie flat for mental stress testing
  • Pre-menopausal
  • Pregnant
  • Pericarditis/myocarditis
  • History of percutaneous coronary intervention
  • Coronary artery bypass grafting
  • Acute myocardial infarction/acute coronary syndrome/unstable angina within 1 month
  • Significant valvular disease, including aortic or mitral stenosis
  • Sinus node dysfunction/pacemaker, 2nd or 3rd-degree atrioventricular block
  • Severe lung, renal, liver, or psychiatric illness
  • Current neoplasm
  • History of substance abuse
  • Acute illness such as infection in the previous 4 weeks
  • Life expectancy is less than 2 years
  • Unable to safely withdraw medications for mental stress testing
  • Significant psychiatric illness that precludes safe participation in the study
  • Conditions that preclude accurate or safe testing and patient refusal
  • Unable to consent Asymptomatic Control Group Inclusion Criteria:
  • Asymptomatic postmenopausal women, age ≥ 45 years old
  • Healthy volunteer with no cardiac risk factors
  • No history or diagnosis of heart disease
  • Not on any cardiac medications
  • Normal maximal exercise treadmill stress testing (ETT)
  • Fully understanding and willing to undergo mental stress testing
  • Willing to sign the informed consent Exclusion Criteria:
  • Significant epicardial stenosis (defined by coronary stenosis ≥ 70% in any epicardial coronary artery or hemodynamically significant stenosis determined by fractional flow reserve)
  • Left ventricular systolic dysfunction (ejection fraction ≤ 50%)
  • Heart failure with a preserved ejection fraction
  • Significant anemia or blood dyscrasia
  • Severe uncontrolled hypertension \>180/100
  • Unable to lie flat for mental stress testing
  • Pre-menopausal
  • Pregnant
  • Pericarditis/myocarditis
  • History of percutaneous coronary intervention
  • Coronary artery bypass grafting
  • Acute myocardial infarction/acute coronary syndrome/unstable angina within 1 month
  • Significant valvular disease, including aortic or mitral stenosis
  • Sinus node dysfunction/pacemaker, 2nd or 3rd-degree atrioventricular block
  • Severe lung, renal, liver, or psychiatric illness
  • Current neoplasm
  • History of substance abuse
  • Acute illness such as infection in the previous 4 weeks
  • Life expectancy is less than 2 years
  • Unable to safely withdraw medications for mental stress testing
  • Significant psychiatric illness that precludes safe participation in the study
  • Orthopedic limitation that will prevent ETT
  • LDL \>120 mg/dL
  • Fasting blood glucose \>95 mg/dL
  • Hypertension, defined as resting BP \>120/80
  • Diabetes
  • Hyperlipidemia
  • Smoking
  • Conditions that preclude accurate or safe testing and patient refusal
  • Unable to consent

The study team makes the final eligibility decision.

Where it's taking place

  • Atlanta, Georgia, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling female, 45 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Atlanta, Georgia, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

ObesityType 2 diabetesType 1 diabetesPrediabetesWeight lossMetabolic syndromeHigh cholesterolHigh triglyceridesHigh blood pressurePCOSHypothyroidismThyroid diseaseGoutFatty liver disease (NAFLD/NASH)Heart failureCoronary artery disease

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.